Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bedminster, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

SEC filing history

Showing 1-25 of 1,000 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-87380

SCHEDULE 13G/A filing

Filing date
05 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-36274

15-12G

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-191238

EFFECT filing

Filing date
09 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-278726

POSASR

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-280463

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-243716

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-236828

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-225799

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-205070

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-193310

S-8 POS

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-191238

POS AM

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-36274

25-NSE filing

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .